104 results
Page 3 of 6
8-K
knce 1r628
16 Nov 21
Other Events
4:15pm
8-K
1hk71 vzw
8 Nov 21
Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress
4:18pm
8-K
EX-99.1
lr6 yveqp
8 Nov 21
Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress
4:18pm
8-K
EX-99.1
5g5glrc6otj4
9 Aug 21
Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress
4:02pm
8-K
lzbm262by
9 Aug 21
Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress
4:02pm
8-K
td7mat n0itl4
10 May 21
Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data
4:21pm
8-K
EX-99.1
a1chhuy3gcx5
10 May 21
Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data
4:21pm
8-K
o2p82b
1 Mar 21
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Positive Clinical Updates
4:20pm
8-K
EX-99.1
xprwp7aj jp2sem
1 Mar 21
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Positive Clinical Updates
4:20pm
424B5
b3ierjl
8 Dec 20
Prospectus supplement for primary offering
5:30pm
8-K
bm3djug emw
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
424B5
5rem6cqc
7 Dec 20
Prospectus supplement for primary offering
5:20pm
S-3ASR
xssttborf
7 Dec 20
Automatic shelf registration
4:15pm